Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen (Covid Vaccines Effectiveness (CoVE))

First published 17/06/2022

Last updated 07/01/2026

EU PAS number:

EUPAS47725

Study

Finalised

Documents

Study protocol

Initial protocol

D2_StudyProtocol_v0.4_ROC12_FINAL_20220615

English (1.12 MB - PDF) View document

Study results

Study report

Other information

Study, other information

ROC12_CoVE_Abstract

English (816.91 KB - PDF) View document

Publications

Study publications

Secondary tabs